Zaghary et al., 2021 - Google Patents
Can nanotechnology overcome challenges facing stem cell therapy? A reviewZaghary et al., 2021
- Document ID
- 8187419972883243860
- Author
- Zaghary W
- Elansary M
- Shouman D
- Abdelrahim A
- Abu-Zied K
- Sakr T
- Publication year
- Publication venue
- Journal of Drug Delivery Science and Technology
External Links
Snippet
Stem cells are undifferentiated cells with a potential to be developed into different types of body cells. Stem cells are used in regenerative medicine as a repair system that is working to restore the structures and functions of damaged tissues and organs aiming to find a way …
- 238000009168 stem cell therapy 0 title description 26
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48776—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form forms of ingredients not provided for by groups A61K47/48784 - A61K47/48992, e.g. cells, cell fragments, viruses, ghosts, red blood cells, viral vectors having the pharmacologically or therapeutically active agent complexed or covalently linked to, or being themselves modified by complexation or covalent linkage by a modifying agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gao et al. | Emerging translational research on magnetic nanoparticles for regenerative medicine | |
Li et al. | Chemical engineering of cell therapy for heart diseases | |
Li et al. | Silica-coated superparamagnetic iron oxide nanoparticles targeting of EPCs in ischemic brain injury | |
Jin et al. | Application of stem cells in regeneration medicine | |
ES2677005T3 (en) | Parenteral composition comprising microspheres with a diameter between 10 and 20 microns | |
Sun et al. | The roles of nanoparticles in stem cell-based therapy for cardiovascular disease | |
Yang et al. | Delivery of miRNAs through metal–organic framework nanoparticles for assisting neural stem cell therapy for ischemic stroke | |
Zhang et al. | The application of nanomaterials in stem cell therapy for some neurological diseases | |
Zamproni et al. | Neurorepair and regeneration of the brain: a decade of bioscaffolds and engineered microtissue | |
Zhang et al. | Particle-based artificial three-dimensional stem cell spheroids for revascularization of ischemic diseases | |
Duan et al. | Superparamagnetic iron oxide-loaded cationic polymersomes for cellular MR imaging of therapeutic stem cells in stroke | |
WO2013059528A2 (en) | Encapsulated diagnostics and therapeutics in nanoparticles-conjugated to tropic cells and methods for their use | |
Corradetti et al. | Nanotechnology for mesenchymal stem cell therapies | |
Alzate-Correa et al. | Nanotechnology-driven cell-based therapies in regenerative medicine | |
Nemeth et al. | Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology | |
Kurakula et al. | Trends of chitosan based delivery systems in neuroregeneration and functional recovery in spinal cord injuries | |
Zimmermann et al. | Nanotechnology for the treatment of spinal cord injury | |
Tajabadi et al. | Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions | |
Zarepour et al. | Combination therapy using nanomaterials and stem cells to treat spinal cord injuries | |
Chung et al. | Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration | |
Escobar et al. | Nanoparticles for neurotrophic factor delivery in nerve guidance conduits for peripheral nerve repair | |
Mandpe et al. | Role of liposomes-based stem cell for multimodal cancer therapy | |
Hoseinzadeh et al. | Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process | |
Gil-Cabrerizo et al. | Development of an injectable alginate-collagen hydrogel for cardiac delivery of extracellular vesicles | |
Jin et al. | Next generation of neurological therapeutics: Native and bioengineered extracellular vesicles derived from stem cells |